Evidence map›Paper›PMID 26456803›Full record

Observational studyInfection control and hospital epidemiology2016

Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.

Theodoros Kelesidis, Nikolay Braykov, Daniel Z Uslan, Daniel J Morgan, Sumanth Gandra, Birgir Johannsson, Marin L Schweizer, Scott A Weisenberg, Heather Young, Joseph Cantey and 4 more

Registry-linked trialOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in Infection control and hospital epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03489330 (A Retrospective Study to Understand the Risk Factors/Drivers of "Inappropriate" Antimicrobial Use and the Performance Evaluation of a Clinical Decision Support Tool That Facilitates Prediction of Outbreaks of Inappropriate Antibiotic Use), which is not on this map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03489330 completednot on this map

A Retrospective Study to Understand the Risk Factors/Drivers of "Inappropriate" Antimicrobial Use and the Performance Evaluation of a Clinical Decision Support Tool That Facilitates Prediction of Outbreaks of Inappropriate Antibiotic Use

TypeobservationalSponsorMidwestern UniversityRan2014 to 2020Enrolled2,000ConditionsInfectious Disease
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Pooled it
  2. Prevalence of extended spectrum beta lactamase and molecular detection of blaInternational microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Article
  4. Protamine protects against vancomycin-induced kidney injury.Antimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Use of the DMAIC Lean Six Sigma quality improvement framework to improve beta-lactam antibiotic adequacy in the critically ill.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Evaluation of antibiotic escalation in response to nurse-driven inpatient sepsis screen.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2021
    Article
  15. Challenges of Antibiotic Stewardship in the Pediatric and Neonatal Intensive Care Units.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 2 countries.

Theodoros Kelesidis1Infectious Diseases,David Geffen School of Medicine/University of California,Los Angeles,Los Angeles,California.
Nikolay Braykov2Center for Disease Dynamics,Economics & Policy,Washington,DC.
Daniel Z Uslan1Infectious Diseases,David Geffen School of Medicine/University of California,Los Angeles,Los Angeles,California.
Daniel J Morgan2Center for Disease Dynamics,Economics & Policy,Washington,DC.
Sumanth Gandra2Center for Disease Dynamics,Economics & Policy,Washington,DC.
Birgir Johannsson4Iowa City Veterans Administration Health Care System,Iowa City,Iowa.
Marin L Schweizer4Iowa City Veterans Administration Health Care System,Iowa City,Iowa.
Scott A Weisenberg5Alta Bates Summit Medical Center,Oakland,California.
Heather Young6Denver Health Medical Center,Denver,Colorado.
Joseph Cantey7Department of Pediatrics,University of Texas Southwestern,Dallas,Texas.
Eli Perencevich4Iowa City Veterans Administration Health Care System,Iowa City,Iowa.
Edward Septimus8Texas A&M Health Science Center College of Medicine,Houston,Texas.
Arjun Srinivasan10Centers for Disease Control and Prevention,Atlanta,Georgia.
Ramanan Laxminarayan2Center for Disease Dynamics,Economics & Policy,Washington,DC.
Iowa City VA Health Care System · USCenter for Disease Dynamics, Economics & Policy · USUniversity of California, Los Angeles · USAlta Bates Summit Medical Center · USCenters for Disease Control and Prevention · USHCA Healthcare · USPrinceton University · USThe University of Texas Southwestern Medical Center · USUniversity of Colorado Denver · USVA Maryland Health Care System · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
University of Iowa Clinical and Translational Science ProgramUL1TR000442 · NCATS · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2012 to 2013
$10.0M
The effectiveness of copper surfaces in reducing healthcare acquired infectionsR01HS021188 · AHRQ · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI USLAN, DANIEL ZACHARY · 2012 to 2016
$2.1M
Oxidized HDL in the intersection of HIV, immune activation and atherosclerosisK08AI108272 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2013 to 2017
$915k
AHRQ HHS R01 HS021188NCATS NIH HHS 2 UL1 TR000442-06NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR000442NIAID NIH HHS K08 AI108272PHS HHS GS-10F-0163P
6 · The paper itself

Abstract

BACKGROUND To design better antimicrobial stewardship programs, detailed data on the primary drivers and patterns of antibiotic use are needed. OBJECTIVE To characterize the indications for antibiotic therapy, agents used, duration, combinations, and microbiological justification in 6 acute-care US facilities with varied location, size, and type of antimicrobial stewardship programs. DESIGN, PARTICIPANTS, AND SETTING Retrospective medical chart review was performed on a random cross-sectional sample of 1,200 adult inpatients, hospitalized (>24 hrs) in 6 hospitals, and receiving at least 1 antibiotic dose on 4 index dates chosen at equal intervals through a 1-year study period (October 1, 2009-September 30, 2010). METHODS Infectious disease specialists recorded patient demographic characteristics, comorbidities, microbiological and radiological testing, and agents used, dose, duration, and indication for antibiotic prescriptions. RESULTS On the index dates 4,119 (60.5%) of 6,812 inpatients were receiving antibiotics. The random sample of 1,200 case patients was receiving 2,527 antibiotics (average: 2.1 per patient); 540 (21.4%) were prophylactic and 1,987 (78.6%) were therapeutic, of which 372 (18.7%) were pathogen-directed at start. Of the 1,615 empirical starts, 382 (23.7%) were subsequently pathogen-directed and 1,231 (76.2%) remained empirical. Use was primarily for respiratory (27.6% of prescriptions) followed by gastrointestinal (13.1%) infections. Fluoroquinolones, vancomycin, and antipseudomonal penicillins together accounted for 47.1% of therapy-days. CONCLUSIONS Use of broad-spectrum empirical therapy was prevalent in 6 US acute care facilities and in most instances was not subsequently pathogen directed. Fluoroquinolones, vancomycin, and antipseudomonal penicillins were the most frequently used antibiotics, particularly for respiratory indications. Infect. Control Hosp. Epidemiol. 2015;37(1):70-79.

Indexed as

AdultAgedAnti-Bacterial AgentsAntibiotic ProphylaxisCross-Sectional StudiesEscherichia coli InfectionsFluoroquinolonesGastrointestinal DiseasesHospitalsHumansMiddle AgedPenicillinsPseudomonas InfectionsRandom AllocationRespiratory Tract InfectionsRetrospective StudiesAnti-Bacterial AgentsFluoroquinolonesPenicillinsVancomycin

Identifiers

PMID26456803
PMCPMC7011437
OpenAlexW2272253185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.